Headlines in Dermatology Registration Now Open for Inaugural H&W Global Dermatology CME Conference in November 2025
Cutaneous Oncology Milestone Alert: More Than 300,000 Patients With Suspicious Lesions Have Been Assessed Using Nevisense
Biosimilars U.S. FDA Grants Interchangeability Designation to Samsung Bioepis and Organon’s Humira Biosimilar
